Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Dino's Bar & Grill -- Ignore unavailable to you. Want to Upgrade?

To: Andrew~ who wrote (40533)	2/1/2018 11:02:23 AM
From: Andrew~	Read Replies (1) \| Respond to of 203656

Liberty Leaf Holdings Ltd. (LIB-Cse) Liberty Leaf Announces the Appointment of Dr. Robert Jackman as Scientific Project Manager Vancouver, B.C. – February 1, 2018: Liberty Leaf President & CEO, Will Rascan, announced today the appointment of Dr. Robert Jackman as Scientific Project Manager/Fulfillment. Liberty Leaf Holdings Ltd. (CSE: LIB, OTCQB: LIBFF and FSE: HN3P) (“Liberty Leaf”) is a Canadian-based, public company whose objective is to be at the forefront of the cannabis industry, accelerating revenue-generating businesses within this rapidly growing sector. "We are very pleased to welcome Dr. Jackman," said Will Rascan, President and CEO of Liberty Leaf Holdings, Ltd. "He brings a wealth of scientific experience and expertise to the team that will prove invaluable over the coming months and years." Dr. Jackman has enjoyed an extensive career as a consultant in research and development, following an illustrious track record in Academia. He has shepherded a number of new products through the vetting process, helping to bring innovative patents to market successfully. Furthermore, Dr. Jackman has worked closely with multiple clients in the Medical Cannabis and Natural and Non-prescription Health Products (NNHP) Industries in North America to facilitate, prepare and submit Licensed Producer, NNHP and site licenses. Among wide-ranging responsibilities, Dr. Jackman will be spearheading a variety of activities for Liberty Leaf, North Road Ventures, Just Kush and other Liberty Leaf enterprises, including identifying and assessing science-based projects. "I am delighted to be part of the Liberty Leaf success story as it unfolds," Dr. Jackman said. "I consider this to be a great honour and opportunity." Over 25 Peer-Reviewed Journal Articles, 6 Book Chapters, 2 Patents, and Several Records of Invention Dr. Jackman is a Food Scientist, with an undergraduate degree (BSc, Hon) from the University of British Columbia, as well as graduate degrees (MSc, PhD) from the University of Guelph. Since 2002, Dr. Jackman has been providing R&D and technical support services to the Food, NNHP and Medical Cannabis industries: Advising corporate clients on regulatory and GMP compliance mattersPreparing and implementing Standard Operating Procedures and policiesTroubleshooting process and product non-conformances and off-specificationsRecommending corrective and preventive actions and process and product improvementsPreparing site and product license applications, and industry SR&ED tax claim reportsAnalyzing and interpreting analytical and technical dataAnd recommending tests, methods and/or processes to ensure product quality and compliance Dr. Jackman has been successful in obtaining over 60 NNHP Licenses, most for difficult to license combination products, and several NNHP site licenses, on behalf of multiple and diverse clients. "The vertically-integrated business interests of Liberty Leaf provide almost limitless growth potential," said Dr. Jackman. "I am confident in being able to help sustain this growth potential by leading special projects and providing sound scientific guidance and expertise." About Liberty Leaf Liberty Leaf Holdings Ltd. is a Canadian-based, public company whose focus is to build and support a diversified portfolio of cannabis-sector businesses, including cultivation, processing, value-added CBD/THC pet products and supply-chain products within this dynamic and fast-growing sector. Liberty Leaf’s late-stage ACMPR portfolio consists of a 60% interest in Just Kushand 100% of North Road Ventures. For further info on the Company please visit libleaf.us16.list-manage.com or email info@libleaf.com On behalf of the Board Will Rascan, President & CEO Liberty Leaf Holdings Ltd. Phone: 778-819-0244